Decreased Activity and Genetic Polymorphisms of CYP2C19 in Behçet's Disease-Reference-Cited by-同舟云学术

Decreased Activity and Genetic Polymorphisms of CYP2C19 in Behçet's Disease

Published:2017-09-06 Issue:4 Volume:121 Page:266-271
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

Goktas Mustafa Tugrul¹²,Karaca Ragip Ozgur¹,Kalkisim Said¹,Cevik Lokman¹,Kilic Levent³,Akdogan Ali³,Babaoglu Melih O.¹,Bozkurt Atilla⁴,Bertilsson Leif⁵,Yasar Umit¹

Affiliation:

1. Department of Pharmacology; Faculty of Medicine; Hacettepe University; Ankara Turkey

2. Department of Medical Pharmacology; Faculty of Medicine; Yildirim Beyazit University; Ankara Turkey

3. Department of Rheumatology; Faculty of Medicine; Hacettepe University; Ankara Turkey

4. Department of Pharmacology; Faculty of Medicine; BAU International University; Batumi Georgia

5. Department of Laboratory Medicine; Division of Clinical Pharmacology at Karolinska Institutet; Karolinska University Hospital; Huddinge Sweden

Funder

Hacettepe University Scientific Research Projects Coordination Unit

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcpt.12710/fullpdf

Reference38 articles.

1. Pathophysiological relationship between infections and systemic vasculitis;Munoz-Grajales;Autoimmune Dis,2015

2. Silk Route disease;James;Postgrad Med J,1986

3. Prevalence of Behcet's disease in Istanbul, Turkey;Azizlerli;Int J Dermatol,2003

4. Behcet's disease;Sakane;N Engl J Med,1999

5. Clinical manifestations of Behcet's disease: an analysis of 2147 patients;Gurler;Yonsei Med J,1997

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of genetic polymorphisms of CYP2J2, CYP2C9, CYP2C19, CYP4F2, CYP4F3 and CYP4A11 enzymes in preeclampsia and gestational hypertension;Placenta;2023-06

2. Towards next-generation personalization of tacrolimus treatment: a review on advanced diagnostic and therapeutic approaches;Pharmacogenomics;2021-11

3. Clinical and Molecular Perspectives on Inflammation‐Mediated Regulation of Drug Metabolism and Transport;Clinical Pharmacology & Therapeutics;2021-10-27

4. Effects of Cytochrome p450 (CYP) 2C19 Genetic Polymorphisms on Voriconazole Serum Levels: A Report of Two Cases;Mediterranean Journal of Infection Microbes and Antimicrobials;2021-07-14

5. Dermatomyositis: immunological landscape, biomarkers, and potential candidate drugs;Clinical Rheumatology;2021-01-03